Article Sidebar
Main Article Content
Total Metabolic Syndrome Score in Addition To FIB-4 Score May Be Useful in Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Main Article Content
Abstract
Cite this article as: Gurbuz B, Koylu B, Keskin O. Total metabolic syndrome score in addition to FIB-4 score may be useful in predicting advanced fibrosis in metabolic dysfunction-associated steatotic liver disease. Turk J Gastroenterol. Published online May 20, 2025. doi 10.5152/tjg.2025.25058.
Article Details
References
1. Şahintürk Y, Köker G, Koca N, et al. Metabolic dysfunction-associated fatty liver disease and fibrosis status in patients with type 2 diabetes treated at internal medicine clinics: Türkiye DAHUDER awareness of fatty liver disease (TR-DAFLD) Study. Turk J Gastroenterol. 2024;35(8):643-650. [CrossRef]
2. Üçbilek E, Yıldırım AE, Ellik Z, et al. Changing trends in the etiology of cirrhosis in Türkiye: A multicenter nationwide study. Turk J Gastroenterol. 2024;35(10):772-777. [CrossRef]
3. Köylü B, Günegül Y, Sökmensüer C, et al. Biyopsi tanılı nonalkolik steatohepatit hastalarında fibrozis evrelerine göre metabolik sendrom komponentlerinin sıklıklarının karşılaştırılması: metabolik bozukluk sayısındaki artış fibrozis progresyonunda etkili mi? Akad Gastroenteroloji Derg. 2022;20(3):143-149. [CrossRef]
4. DeBoer MD, Lin B, Filipp SL, Cusi K, Gurka MJ. Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis. Nutr Res. 2021;88:34-43. [CrossRef]
5. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388-1402. [CrossRef]